Evidence map›Paper›PMID 36725770›Full record

SynthesisNeurosurgical review2023

Current advances in the surgical treatment of glossopharyngeal neuralgia.

Manuela Aramburu Berckemeyer, Paola Suarez-Meade, Maria Fernanda Villamonte Carcelen, Mariel Dyer Ricci, William P Cheshire, Daniel M Trifiletti, Erik H Middlebrooks, Alfredo Quinones-Hinojosa, Sanjeet S Grewal

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Neurosurgical review, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Manuela Aramburu BerckemeyerSchool of Medicine, Faculty of Biomedical Science and Health, Universidad Europea de Madrid, Madrid, Spain.
Paola Suarez-MeadeDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA.
Maria Fernanda Villamonte CarcelenSchool of Medicine, Faculty of Human Medicine, Universidad San Martin de Porres, Lima, Peru.
Mariel Dyer RicciSchool of Medicine, Faculty of Human Medicine, Universidad San Martin de Porres, Lima, Peru.
William P CheshireDepartment of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Daniel M TrifilettiDepartment of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA.
Erik H MiddlebrooksDepartment of Radiology, Mayo Clinic, Jacksonville, FL, USA.
Alfredo Quinones-HinojosaDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA.
Sanjeet S GrewalDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA. Grewal.sanjeet@mayo.edu.
WinnMed · USMayo Clinic in Florida · USUniversidad de San Martín de Porres · PENeurological Surgery · USUniversidad Europea de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glossopharyngeal neuralgia (GPN) is a neurological condition characterized by paroxysmal, stabbing-like pain along the distribution of the glossopharyngeal nerve that lasts from a couple of seconds to minutes. Pharmacological treatment with anticonvulsants is the first line of treatment; however, about 25% of patients remain symptomatic and require surgical intervention, which is usually done via microvascular decompression (MVD) with or without rhizotomy. More recently, the use of stereotactic radiosurgery (SRS) has been utilized as an alternative treatment method to relieve patient symptoms by causing nerve ablation. We conducted a systematic review to analyze whether MVD without rhizotomy is an equally effective treatment for GPN as MVD with the use of concurrent rhizotomy. Moreover, we sought to explore if SRS, a minimally invasive alternative surgical option, achieves comparable outcomes. We included retrospective studies and case reports in our search. We consulted PubMed and Medline, including articles from the year 2000 onwards. A total of 36 articles were included for review. Of all included patients with glossopharyngeal neuralgia, the most common offending artery compressing the glossopharyngeal nerve was the posterior inferior cerebellar artery (PICA). MVD alone was successful achieving pain relief immediately postoperatively in about 85% of patients, and also long term in 65-90% of patients. The most common complication found on MVD surgery was found to be transient hoarseness and transient dysphagia. Rhizotomy alone shows an instant pain relief in 85-100% of the patients, but rate of long-term pain relief was lower compared to MVD. The most common adverse effects observed after a rhizotomy were dysphagia and dysesthesia along the distribution of the glossopharyngeal nerve. SRS had promising results in pain reduction when using 75 Gy radiation or higher; however, long-term rates of pain relief were lower. MVD, rhizotomy, and SRS are effective methods to treat GPN as they help achieve instant pain relief and the decrease use of medication. Patients with MVD alone presented with less adverse effects than the group that underwent MVD plus rhizotomy. Although SRS may be a viable alternative treatment for GPN, further studies must be done to evaluate long-term treatment efficacy.

Indexed as

Deglutition DisordersGlossopharyngeal Nerve DiseasesMicrovascular Decompression SurgeryTrigeminal NeuralgiaHumansPainRetrospective StudiesTreatment OutcomeVertebral ArteryCranial nervesGlossopharyngeal nerve diseaseMicrovascular decompression surgeryNerve compression syndromesRadiosurgeryTreatment outcomes

Identifiers

PMID36725770
OpenAlexW4318761830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.